2:14 p.m. ET -- GSK is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The European Commission on Wednesday European Commission has authorized the company's Arexvy, a respiratory syncytial virus vaccine, for use in Europe. GSK said RSV, a common, contagious respiratory virus, leads to over 270,000 hospitalizations and about 20,000 in-hospital deaths each year in adults aged 60 years and over in Europe. Dow Jones & Co. owns Factiva. (stephen.nakrosis@wsj.com)

(END) Dow Jones Newswires

June 07, 2023 14:30 ET (18:30 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Gsk.
Gsk (LSE:GSK)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Gsk.